Countries South Korea
Samsung Biologics Launches CHF 1.46B All-Cash Bid to Acquire PolyPeptide
Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury share...
July 20, 2026 | News
Why Korea, Why Now? Korean Biotech Looks to Taiwan as Asia’s Next Partnership Frontier
Korea’s biotechnology industry is entering a new phase of global ambition. Having established significant capabilities across biopharmaceutical manuf...
July 20, 2026 | News
APAC's Peptide-Capacity Gamble
For most of pharmaceutical history, the hard part was finding a molecule that worked. The GLP-1 class inverted that logic. The science arrived first &mdash...
July 09, 2026 | Analysis
LG Chem and OTR Therapeutics Partner to Advance China-Sourced Oncology Assets Globally
OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, today an...
July 09, 2026 | News
The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
In Songdo and Bengaluru, the numbers finally look like the ones the region was promised a decade ago. Celltrion closed 2025 with revenue above ₩4 trillio...
July 07, 2026 | Analysis
SK Bioscience to Lead Gates Foundation-Backed AI Platform for Vaccine Clinical Development
SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework. SK bioscience, PATH, Slalom...
July 06, 2026 | News
Samsung Biologics Accelerates Sustainability Strategy with Stronger ESG Performance
Advanced environmental performance through renewable energy transition and enhanced carbon transparency Strengthened sustainability management and suppl...
July 02, 2026 | News
PharmaResearch Expands U.S. Footprint with CG USA Acquisition to Boost REJURAN Cosmetics Growth
Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, ...
July 01, 2026 | News
Can APAC Build Radioligand Therapy Before the Atoms Decay?
Every dose of radioligand therapy is a countdown. The moment a batch of lutetium-177 leaves the reactor, it begins to fade — roughly half its therape...
July 02, 2026 | Analysis
Samsung Bioepis and ATLATL Launch Innovation Prize to Accelerate Asia-Pacific Biotech Startups
Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies ATLATL Innovation Center ("A...
June 26, 2026 | News
Samsung Bioepis and Organon Expand Canadian Biosimilars Alliance with PYZCHIVA® Commercialisation Agreement
Samsung Bioepis and Organon, a global healthcare company with a deep expertise in biosimilars, announced the expansion of their development and commer...
June 23, 2026 | News
LG AI Research and D&D Pharmatech Join Forces to Accelerate AI-Powered Oral Peptide Drug Discovery
- LG to secure leadership in the AI-bio market with its distinctive technological edge. LG AI Research announced that it has signed a ...
June 19, 2026 | News
Dimerix Signs Up to AU$481 Million Licensing Deal with Everest Medicines to Advance Phase 3 Kidney Disease Therapy Across Asia
Dimerix Limited (ASX: DXB), a biopharmaceutical company developing innovative therapies for rare inflammatory diseases, has entered into an exclusive licen...
June 17, 2026 | News
SK Bioscience Licenses CDC Rotavirus Vaccine Technology to Advance Global Immunisation Efforts
SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with t...
June 11, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
